Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [ (11)C]Telmisartan

The angiotensin receptor blocker telmisartan slows progression of kidney disease in patients with type 2 diabetes (T2D), yet many patients remain at high risk for progressive kidney function loss. The underlying mechanisms for this response variation might be attributed to differences in angiotensin...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Hoek, Sjoukje, Mulder, Douwe J., Willemsen, Antoon T.M., Visser, Ton, Heeres, Andre, Slart, Riemer H.J.A., Elsinga, Philip H., Heerspink, Hiddo J.L., Stevens, Jasper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827889/
https://www.ncbi.nlm.nih.gov/pubmed/36070078
http://dx.doi.org/10.1002/cpt.2744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827889/
https://www.ncbi.nlm.nih.gov/pubmed/36070078
http://dx.doi.org/10.1002/cpt.2744

Ejemplares similares